Home Page > Hearing - 110th Congress

HEARING

The Adequacy of FDA Efforts to Assure the Safety Efforts of the Drug Supply -- Part II

Subcommittee on Oversight and Investigations
March 22, 2007 10:00 a.m.
The Adequacy of FDA to Assure the Safety of the Drug Supply- Part II

Hearing Webcast

(Any use of this recording is subject to Rule XI, 4 of the House of Representatives. See text of Rule XI, 4 as posted by the House Committee on Rules.)

Watch the Archived Video Webcast of this Hearing (100 kbps) or Download

Windows Media Player is required for Committee Webcasts.

Witness List & Prepared Testimony (pdf files)

Panel I
The Hon. Andrew C. von Eschenbach, M.D. Commissioner U.S. Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857
Panel II
Bruce M. Psaty, M.D., Ph.D. Professor of Medicine, Epidemiology and Health Services Cardiovascular Health Research Unit University of Washington School of Public Health and Community Medicine Institute of Medicine Committee on the Assessment of the U.S. Drug Safety System	Curt D. Furberg, M.D., Ph.D. Professor of Public Health Services Division of Public Health Services Wake Forest University School of Medicine FDA Advisory Committee on Drug Safety
Marcia G. Crosse, Ph.D. Director, Public Health and Military Health Care Issues U.S. Government Accountability Office Accompanied by Martin T. Gahart, Ph.D. Assistant Director	Raymond L. Woosley, M.D., Ph.D. President and CEO The Critical Path Institute

Printed Hearing

Serial No. 110-5 -- The Adequacy of FDA to Assure the Safety of the Nation's Drug Supply, March 22, 2007
TEXT (580K) | PDF (7.4M)

(The text and pdf transcript links direct you to the Government Printing Office Access Web site at http://www.access.gpo.gov/congress/house/house05ch110.html)